Standard BioTools's market cap is currently $502.55M. The company's EPS TTM is $-0.709; its P/E ratio is ―; Standard BioTools is scheduled to report earnings on February 12, 2025, and the estimated EPS forecast is $-0.06. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 106.34M	$ 97.95M	$ 130.58M	$ 138.14M	$ 117.24M
Gross Profit	$ 50.45M	$ 37.05M	$ 69.37M	$ 83.33M	$ 64.28M
Operating Income	$ -76.60M	$ -116.20M	$ -67.46M	$ -51.04M	$ -51.84M
EBITDA	$ -54.46M	$ -173.57M	$ -43.77M	$ -34.60M	$ -46.62M
Net Income	$ -74.66M	$ -190.10M	$ -59.24M	$ -53.02M	$ -64.79M
Balance Sheet
Cash & Short-Term Investments	$ 114.89M	$ 165.78M	$ 28.45M	$ 68.52M	$ 58.64M
Total Assets	$ 323.07M	$ 390.31M	$ 275.21M	$ 324.76M	$ 264.81M
Total Debt	$ 98.21M	$ 102.66M	$ 111.65M	$ 95.38M	$ 59.98M
Net Debt	$ 46.51M	$ 21.35M	$ 83.20M	$ 26.86M	$ 38.32M
Total Liabilities	$ 159.87M	$ 471.78M	$ 180.62M	$ 185.71M	$ 111.20M
Stockholders' Equity	$ 163.20M	$ -81.47M	$ 94.60M	$ 139.05M	$ 153.61M
Cash Flow
Free Cash Flow	$ -46.12M	$ -93.19M	$ -57.33M	$ -28.13M	$ -37.74M
Operating Cash Flow	$ -43.29M	$ -89.37M	$ -44.06M	$ -15.42M	$ -35.21M
Investing Cash Flow	$ 20.24M	$ -88.13M	$ -11.95M	$ 39.98M	$ -39.30M
Financing Cash Flow	$ -6.81M	$ 230.76M	$ 15.96M	$ 20.86M	$ 2.79M

Currency in USD

Standard BioTools Earnings and Revenue History

Income Statement >

Standard BioTools Debt to Assets

Balance Sheet >

Standard BioTools Cash Flow

Cash Flow >

Standard BioTools Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing